Human Mpox in People Living with HIV: Epidemiologic and Clinical Perspectives from Nigeria

被引:0
|
作者
Iroezindu, Michael O. [1 ,2 ]
Crowell, Trevor A. [2 ,3 ]
Ogoina, Dimie [4 ]
Yinka-Ogunleye, Adesola [5 ]
机构
[1] HJF Med Res Int, Clin Res Ctr, Abuja 900271, Nigeria
[2] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA
[3] Henry M Jackson Fdn Advancement Mil Med, Bethesda, MD USA
[4] Niger Delta Univ, Teaching Hosp, Infect Dis Unit, Okolobiri, Nigeria
[5] Univ Coll London UCL, Inst Global Hlth, London, England
关键词
HIV; mpox; sexual and gender minorities; sexual behavior; clinical outcome; surveillance; SEXUALLY-TRANSMITTED INFECTIONS; HUMAN MONKEYPOX;
D O I
10.1089/aid.2023.0034
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sub-Saharan Africa (SSA) is disproportionately affected by mpox and HIV. We described epidemiologic trends and clinical experiences in the management of mpox in people living with HIV (PLWH) in Nigeria and further examined how the rapidly accumulating body of knowledge from the 2022 global mpox outbreak might be explored to improve mpox care in PLWH in SSA. During the 2017/2018 Nigerian mpox outbreak, we reported that 9/40 (22.5%) hospitalized mpox patients with known HIV status were PLWH. In the 2022 global mpox outbreak, 52% of confirmed mpox cases with known HIV status were PLWH, predominantly sexual and gender minority groups. However, substantial missing data on HIV status of confirmed mpox cases highlights a critical gap in HIV testing as a component of mpox management. Before 2022, sexual activity was not commonly linked to mpox transmission, but this was identified as a major driver of transmission during the 2022 mpox outbreak. Notable sexual history observed in Nigerian mpox patients in 2017/2018 suggests that the contribution of sexual activity in human-to-human mpox transmission might have been underappreciated for years. Our cohort of PLWH with mpox, predominantly individuals with advanced or uncontrolled HIV, were significantly more likely to experience severe mpox manifestations and prolonged disease compared with those without HIV. This contrasts with the generally less remarkable differences in mpox presentation between people with and without HIV in Western countries, an observation that can be at least partially explained by more stable HIV disease. The unavailability of mpox antiviral drugs and vaccines in SSA highlights global inequity in mpox response, which requires an urgent attention. As mpox countermeasures become available in SSA, lessons learned from their use in Western countries could provide important guidance for care providers in SSA. Public health measures to mitigate stigmatization in PLWH with mpox is also critical.
引用
收藏
页码:593 / 600
页数:8
相关论文
共 50 条
  • [1] Mpox infection in people living with HIV
    Heath, Sonya L.
    Bansal, Anju
    [J]. AIDS, 2023, 37 (04) : 701 - 703
  • [2] Risk perception and mpox vaccine acceptability among people living with HIV in northern Nigeria
    Iliyasu, Z.
    Kwaku, A.
    Amole, T.
    Tsiga-Ahmed, F.
    Umar, A.
    Bashir, H.
    Fontana, B.
    Salihu, H.
    Aliyu, M.
    [J]. HIV MEDICINE, 2023, 24 : 328 - 328
  • [3] Assessment of Knowledge and Concern of People Living with HIV Regarding Human Mpox and Vaccination
    Borcak, Deniz
    Ozdemir, Yusuf Emre
    Zuhal, Yesilyurt
    Ensaroglu, Esra
    Akkaya, Samiha
    Yasar, Kadriye Kart
    [J]. CURRENT HIV RESEARCH, 2024, 22 (02) : 120 - 127
  • [4] ART initiation for people living with HIV with severe mpox
    Wong, Marcia
    Damon, Inger K.
    Zucker, Jason
    Foote, Mary M. K.
    El-Sadr, Wafaa
    [J]. LANCET, 2020, 402 (40414): : 1750 - 1750
  • [5] Clinical presentation of mpox in people with and without HIV
    Pilkington, Victoria
    Quinn, Killian
    Campbell, Lucy
    Brady, Michael
    Post, Frank
    [J]. HIV MEDICINE, 2023, 24 : 7 - 8
  • [6] Clinical course of Mpox among people with HIV: A 2022 cohort from Warsaw, Poland
    Kowalski, J.
    Cielniak, I.
    Garbacz-Lagozna, E.
    Nska, G. Cholewi Nska-Szyma
    Parczewski, M.
    [J]. HIV MEDICINE, 2023, 24 : 326 - 327
  • [7] Mpox outbreak among people living with and without HIV in Argentina: The VIHpox study
    Mauas, R.
    Rolon, M. J.
    Montaldo, F.
    Lopardo, G.
    Fiori, A.
    Tisne, A.
    Obieta, E.
    Pelaez, S.
    Cuini, R.
    Cacciari, V.
    Greco, M. M.
    Copertari, G.
    Calanni, L.
    Parenti, P.
    Castro, G. A.
    Erviti, A.
    Brizuela, M.
    Rombini, M. F.
    Bottaro, E.
    Cecchini, D.
    Cassetti, I.
    [J]. HIV MEDICINE, 2023, 24 : 331 - 332
  • [8] Access to HIV care in jails: Perspectives from people living with HIV in North Carolina
    Blue, Colleen
    Buchbinder, Mara
    Brown, Mersedes E.
    Bradley-Bull, Steve
    Rosen, David L.
    [J]. PLOS ONE, 2022, 17 (01):
  • [9] Serosurvey of Immunity to Monkeypox (Mpox) Virus Antigens in People Living with HIV in South Florida
    Kupritz, Jonah
    Pahwa, Savita
    Pallikkuth, Suresh
    [J]. PATHOGENS, 2023, 12 (11):
  • [10] SEXUAL PRACTICES OF PEOPLE LIVING WITH HIV IN SOUTH EASTERN NIGERIA
    Ikechebelu, J. I.
    Mbamara, S. U.
    Joe-Ikechebebelu, N. N.
    Ezenwabachili, A. O.
    [J]. NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2009, 12 (04) : 416 - 420